These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 8246226
1. Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors. Satoh Y, Stanton JL, Hutchison AJ, Libby AH, Kowalski TJ, Lee WH, White DH, Kimble EF. J Med Chem; 1993 Nov 12; 36(23):3580-94. PubMed ID: 8246226 [Abstract] [Full Text] [Related]
2. Derivatives of 2-[[N-(Aminocarbonyl)-N-hydroxyamino]methyl]-1,4- benzodioxan as orally active 5-lipoxygenase inhibitors. Satoh Y, Powers C, Toledo LM, Kowalski TJ, Peters PA, Kimble EF. J Med Chem; 1995 Jan 06; 38(1):68-75. PubMed ID: 7837242 [Abstract] [Full Text] [Related]
3. Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase. Malamas MS, Carlson RP, Grimes D, Howell R, Glaser K, Gunawan I, Nelson JA, Kanzelberger M, Shah U, Hartman DA. J Med Chem; 1996 Jan 05; 39(1):237-45. PubMed ID: 8568813 [Abstract] [Full Text] [Related]
4. CGS 22745: a selective orally active inhibitor of 5-lipoxygenase. Kimble E, Kowalski T, White D, Raychauduri A, Pastor G, Chertock H, Lee W, Neale R, Hamdan A, Wasley J. Agents Actions; 1991 Sep 05; 34(1-2):125-8. PubMed ID: 1665286 [Abstract] [Full Text] [Related]
5. Thiopyranol[2,3,4-c,d]indoles as inhibitors of 5-lipoxygenase, 5-lipoxygenase-activating protein, and leukotriene C4 synthase. Hutchinson JH, Charleson S, Evans JF, Falgueyret JP, Hoogsteen K, Jones TR, Kargman S, Macdonald D, McFarlane CS, Nicholson DW. J Med Chem; 1995 Oct 27; 38(22):4538-47. PubMed ID: 7473582 [Abstract] [Full Text] [Related]
6. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity. Hamer RR, Tegeler JJ, Kurtz ES, Allen RC, Bailey SC, Elliott ME, Hellyer L, Helsley GC, Przekop P, Freed BS, White J, Martin LL. J Med Chem; 1996 Jan 05; 39(1):246-52. PubMed ID: 8568814 [Abstract] [Full Text] [Related]
9. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones. Bhatia PA, Brooks CD, Basha A, Ratajczyk JD, Gunn BP, Bouska JB, Lanni C, Young PR, Bell RL, Carter GW. J Med Chem; 1996 Sep 27; 39(20):3938-50. PubMed ID: 8831760 [Abstract] [Full Text] [Related]
13. Benzothiazole hydroxy ureas as inhibitors of 5-lipoxygenase: use of the hydroxyurea moiety as a replacement for hydroxamic acid. Greco MN, Hageman WE, Powell ET, Tighe JJ, Persico FJ. J Med Chem; 1992 Aug 21; 35(17):3180-3. PubMed ID: 1324317 [Abstract] [Full Text] [Related]
16. Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics of L-739,010. Hamel P, Riendeau D, Brideau C, Chan CC, Desmarais S, Delorme D, Dubé D, Ducharme Y, Ethier D, Grimm E, Falgueyret JP, Guay J, Jones TR, Kwong E, McAuliffe M, McFarlane CS, Piechuta H, Roumi M, Tagari P, Young RN, Girard Y. J Med Chem; 1997 Aug 29; 40(18):2866-75. PubMed ID: 9288168 [Abstract] [Full Text] [Related]